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Abstract
Background: Sortilin and SorCS2 are part of the Vps10p receptor family. They have both been studied in nervous
tissue with several important functions revealed, while their expression and possible functions in developing peripheral
tissue remain poorly understood. Here we deliver a thorough characterization of the prenatal localization of sortilin and
SorCS2 in mouse peripheral tissue.
Results: Sortilin is highly expressed in epithelial tissues of the developing lung, nasal cavity, kidney, pancreas, salivary
gland and developing intrahepatic bile ducts. Furthermore tissues such as the thyroid gland, developing cartilage and
ossifying bone also show high expression of sortilin together with cell types such as megakaryocytes in the liver.
SorCS2 is primarily expressed in mesodermally derived tissues such as striated muscle, adipose tissue, ossifying bone
and general connective tissue throughout the body, as well as in lung epithelia. Furthermore, the adrenal gland and
liver show high expression of SorCS2 in embryos 13.5 days old.
Conclusions: The possible functions relating to the expression patterns of Sortilin and SorCS2 in development are
numerous and hopefully this paper will help to generate new hypotheses to further our understanding of the Vps10p
receptor family.
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Background
Sortilin and SorCS2 are members of the Vps10p-domain-
containing receptor family [1, 2]. Sortilin is a multi-ligand
receptor shown to function at the level of the Trans Golgi
Network (TGN), plasma membrane and lysosomes in sort-
ing a variety of molecules [3]. Functions of sortilin have
been investigated in the central and peripheral nervous
system (CNS and PNS) and include trafficking and signal-
ing of neurotrophins (NTs) and their receptors [4, 5]. In
particular, the interaction between sortilin, the pro-versions
of nerve growth factor (pro-NGF), brain derived neuro-
trophic factor (pro-BDNF), NT-3, the NT receptor p75NTR
and the resulting apoptotic signals have been well examined
[6–10]. SorCS2 has been studied considerably less but focus
has also been on nervous structures. A recently published
paper from our group has established that SorCS2 exists in
CNS and PNS in single- and two-chain forms that regulate
dopaminergic axon guidance and peripheral sensory
neuron apoptosis, respectively, and interact with pro-
BDNF/p75NTR [2]. Interestingly, SorCS2 has also been
shown to be essential for pro-NGF mediated growth cone
collapse [11]. Variations in the sortilin gene have been
implicated in the processing of amyloid precursor pro-
tein (APP) and essential tremor and variations in the
SorCS2 gene have been shown to occur more fre-
quently in bipolar disorder, schizophrenia and ADHD
suggesting both sortilin and SorCS2 as important for
normal CNS function [12–17]. In addition, recent find-
ings have indicated that sortilin and SorCS2 may be as-
sociated with increased risk of Alzheimer’s disease [18].
Research into the physiological role of sortilin outside the
nervous system has found sortilin to be involved in traf-
ficking of glucose transporter type 4 vesicles [19] and
expressed in several types of cancer cells [20–22].
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Furthermore, GWAS studies have found an allele of the
sortilin gene locus that increases hepatic sortilin expres-
sion and confers a protective effect against cardiovascular
disease [23, 24]. Subsequent studies of this have produced
results suggesting that increased expression of hepatic sor-
tilin reduces levels of low density lipoprotein (LDL)-chol-
esterol in blood, and thereby atherosclerosis [25].
Surprisingly, lack of sortilin also leads to decreased LDL-
cholesterol levels in blood through decreased VLDL secre-
tion [26]. To complicate matters further, sortilin has been
identified as a facilitator of proprotein convertase subtili-
sin/kexin type 9 (PCSK9) secretion, a protein that reduces
LDL-receptor expression [19, 27]. Consequently, the
exact role of sortilin in cholesterol metabolism remains
a matter of debate. Sortilin and SorCS2 are expressed
dissimilarly in the CNS, but seem to have partly over-
lapping functions, with both being able to transmit
apoptotic signals via pro-BDNF and pro-NGF [2, 7].
This relationship of structural and in part functional
similarities combined with complementary expression
patterns might be found outside the CNS as well. Fur-
thermore, the functions of SorCS2 and sortilin with
these neurotrophins are relevant for neurodevelopment
and conceivably so for the maturation of other cell sys-
tems. Thus, it is relevant to study sortilin and SorCS2 to-
gether in non-neuronal tissues. While there is data
concerning the expression of sortilin and SorCS2 mRNA
during development, the focus has so far been on the ner-
vous system. Here, we deliver a thorough description of
the spatiotemporal localization of sortilin and SorCS2 in
organs and peripheral tissue of the developing mouse em-
bryo, hopefully enabling new hypotheses toward their
physiological roles to be created and tested.
Methods
Animals
Animals used for this study were C57j/bl6bom mice.
Sortilin(−/−) and SorCS2(−/−) mice were bred on
C57j/bl6bom background using homologous recom-
bination [4]. All animals were bred and housed at the
Animal Facility at Aarhus University in accordance
with the Danish Animal Protection Act (12/09/2015).
A maximum of five mice per plastic cage (42 x 25 x
15 cm) were housed with water ad libitum and fed
standard chow (Altromin #1324). Cages contained
nesting material, bedding, a metal tunnel and a
wooden stick and were cleaned every week. Animals
were kept under pathogen-free conditions with a 12-h
light/12-h dark schedule. Experiments were approved
by the Danish Animal Experiments Inspectorate
(Permit 2011/561–119). For the expression analysis
three embryos from two different mothers were used
for each age point.
Tissue
Fetal tissue was obtained through timed-pregnant C57j/
bl6bom mice, on embryonic day (E) 13.5, 15.5 and 17.5.
Midday on the day of vaginal plug detection was deter-
mined as E0.5. Pregnant mice were euthanized by cer-
vical dislocation, the uterus removed and transferred to
ice cold phosphate buffered saline (PBS). Embryos were
dissected out and fixed in 4 % paraformaldehyde for 1–2
days. After cryoprotection in 30 % sucrose, embryos
were covered in Tissue-Tek (Sakura, 4583) and
immersed in liquid nitrogen. Sagittal and horizontal sec-
tions were cut at 10 μm using a cryostat (Microm HM
500 OM) and stored at −20 °C until use. Adult
SorCS2(−/−) and sortilin(−/−) mice have no gross abnor-
malities of their organs. Therefore a presumption that
SorCS2 and sortilin do not play a crucial role in the early
organogenesis was made. Age points E13.5, E15.5 and
E17.5 were thus selected as the different organs here are
relatively easy to identify and important maturational
processes take place.
Immunohistochemistry
Antigen-retrieval was performed by microwaving the tis-
sue for 2 × 5 min at 540 W in Target Retrieval Solution
(DAKO, s1699) using a 1:10 dilution in PBS. Sections
were cooled to room temperature, followed by 3x10 min
wash in PBS. To permeabilize the cells and block en-
dogenous reactivity, sections were incubated with PBS
containing 1 % bovine serum albumin (BSA; Sigma,
A4503) and 0.3 % Triton X-100 (Sigma, T8787) for
30 min. After a 10 min washing step, primary antibodies
were added in a 50 nM Tris-based (TB; 6.06 g Tris,
8.77 g NaCl in 1 L H2O, pH 7.4) buffer solution contain-
ing 1 % BSA and sections placed overnight at 4 °C. The
next day, sections were left at room temperature for 1 h
followed by 3 × 10 min of wash in PBS. Secondary anti-
bodies were added in TB and sections left in the dark
for 4 h at room temperature before washing 3 × 10 min.
Nuclei were visualized by incubating with Hoechst stain
using a 1:10,000 dilution in PBS for 10 min. Sections
were mounted using fluorescent mounting medium
(DAKO, s3023) and kept in the dark at 4 °C. Primary
antibodies used were goat α-sortilin (R&D systems,
AF2934,1:100), sheep α-SorCS2 (R&D systems, AF4237,
1:50), rabbit α-TTF-1 (Santa Cruz, H-190,1:250), rabbit
α-calretinin (Milipore, ab5054, 1:250), rabbit α-
Calbindin (Milipore, ab1778, 1:50) and rabbit α-Tyrosine
Hydroxylase (Milipore, AB152, 1:250). Reviews of all
antibodies used have been made public on the anti-
body rating site http://www.pabmabs.com. These
extra primary antibodies were selected during the
study to elaborate on observed sortilin and SorCS2
expression. Secondary antibodies used were donkey
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α-sheep 488, donkey α-goat 488 and donkey α-rabbit 565
(Life Technologies, A-11015, A-11055, A-10042, 1:300).
Images were captured using a Zeiss LSM780 laser-
scanning confocal microscope controlled by ZEN 2011
software. Specificity of sortilin and SorCS2 antibodies
were ensured using sortilin(−/−) and SorCS2(−/−) tissue
[2, 5]. The expression level and localization of sortilin




Nose/upper airways At all three ages E13.5, E15.5 and
E17.5, moderately strong sortilin immunoreactivity (IR)
was found in the epithelium of the nasal cavity. The ex-
pression was localized to the apical part of the epithelial
cells and showed a granular pattern. At E15.5, cells in
the epithelium marked by the calcium-binding protein
calretinin, a marker for maturing olfactory cells [28],
showed sortilin IR as well (Fig. 1a, b). In the respiratory
part of the pharynx as well as the larynx and trachea,
sortilin IR was again found in the apical part of the
epithelial cells, albeit at a weaker level. This pattern was
repeated through E13.5-E17.5. Lastly, strong expression
of sortilin was found in epithelial glands of the nasal
cavity at E17.5 (Fig. 1c).
Lung/Lower airways Sortilin was found highly
expressed in the developing lung, and showed distinct
spatial distribution throughout all three age points. At
E13.5, in the pseudo glandular lung stage, sortilin re-
activity was found to be pronounced in the epithelium
of the entire developing bronchial system as marked by
Thyroid Transcription Factor 1 (TTF-1), a marker for
developing bronchial cells [29]. Expression had a granu-
lar pattern and was most prominent in the apical part of
the epithelial cells (Fig. 1d, d'). The mesenchyme showed
very sparse reactivity. At E15.5, in the early canalicular
phase, the pattern was similar, albeit with a lower ex-
pression of sortilin in more proximal bronchi. At E17.5
in the beginning of the saccular phase the pattern of sor-
tilin had changed somewhat. In the more distal branches
of the tubular system sortilin was highly expressed in
the apical vesicular pattern previously described. How-
ever, in the parts of the airways resembling developing
alveoli, sortilin reactivity was very sparse (Fig. 1e, f ). Fur-
thermore, the mesenchyme/stroma began to show
distinct sortilin IR. Along the borders of the prospect-
ive alveoli and bronchioli, solitary cells with a round
soma approximately 10–12 μm in diameter and
strong granular expression of sortilin were found.
These cells resembled macrophages.
A final note on lungs, preliminary examination of two
Sortilin(−/−) embryos give the impression that at E15.5
the lung epithelium have fewer branches per lung area
and have a larger lumen compared to (two) WT mice.
A comparison is shown in Fig. 2 but this must be
checked in many more mice before a statistically rele-
vant conclusion can be drawn.
In short summary, sortilin IR in the developing re-
spiratory system was largely confined to the apical parts
of epithelia, most pronounced in the roof of the nasal
cavity and in the presumptive more immature stages/
parts of the developing lower airways.
Digestive tract
Mouth and esophagus
At E13.5 the epithelium of the mouth and tongue both
showed sortilin IR at a weak level, stronger in the latter
(Fig. 7a, b). By E15.5 this expression had diminished,
apart from a few epithelial cells dispersed in the poster-
ior palate, and by E17.5, no sortilin-IR could be detected.
In the esophagus, weak sortilin IR in the epithelium was
found consistently at all the three age points.
Submandibular gland
Sortilin showed a distinct expression pattern in the sub-
mandibular gland. Expression was confined to the apical
part of the epithelial cells of acini as well as ducts in a
granular manner at E13.5. This persisted throughout the
course of E15.5-E17.5, as the gland grew larger and more
complex (Fig. 3b).
Gut
At E13.5 sortilin IR was found in midgut, most pro-
nounced in the epithelium, as well as in a circular band
with a thickness of 2–3 cells in the periphery of the gut
wall. In the epithelial cells, sortilin IR was located api-
cally in a granular pattern (v 3a). At E15.5 sortilin IR of
the gut had decreased. In the developing small intestine,
expression of sortilin was present weakly in the epithe-
lium, and strongly in a subset of cells herein. In these
cells sortilin was often located basally to the nucleus in
resemblance of enteroendocrine cells, and sometimes in
a small cellular process extending along the basal epithe-
lial border (Fig. 3a, b' ,c'). In the large intestine, sortilin
IR was noted in the epithelium at a moderate level
(Fig. 3c). The same pattern of expression was apparent
at E17.5 with the addition of expression in the ventricu-
lar epithelium.
Liver
Throughout all three stages investigated, similarities in
sortilin IR were found in the liver. Large cells with in-
tense granular expression of sortilin were found across
the organ. These cells were up to 25 μm in diameter
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with a large lobed nucleus resembling megakaryocytes.
Additionally, a strong granular expression of sortilin was
present in cells harboring a nucleus with several lobes,
resembling neutrophil granulocytes, as well as in cells
with a bended nucleus resembling eosinophils or mono-
cytes. Specifically for E13.5, sortilin IR was found in cells
with an elongated nucleus and cytoplasm that was often
surrounding a single cell or a few identical looking blood
cells of various lineages. At E15.5 and E17.5, clusters of
sortilin IR cells in the near vicinity of large vessel-like
structures were present. These clusters often had a bi-
layered structure surrounding a small lumen, fitting the
morphology of developing intrahepatic bile ducts [30].
Liver findings are shown in Fig. 4.
Fig. 1 Sortilin expression in embryonic respiratory tract. Immunofluorescence was performed on sagittal sections (10 μm) of embryos on embryonic
day E13.5 (d), E15.5 (a, b, d, e) and E17.5 (c, f). Sortilin localizes prominently to the epithelium and glands of the nasal cavity (a, c) and is also found in
the tracheal epithelium (b). Furthermore, sortilin is highly expressed in the apical part of the epithelium of the branching bronchial network at all three
time points investigated. The expression is confined primarily to distal branches and is diminished in proximal more mature bronchi (d, e). Green
channel is sortilin, red channel is calretinin (a) or TTF-1 and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Br, bronchus; Ca, cartilage; Db,
distal branch; Gl, epithelial gland; Na, nasal cavity; Ol, olfactory epithelium; Pl pleuric cavity; Tr, tracheal epithelium
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Pancreas
In the pancreas, sortilin IR was localized to the par-
enchyma of the exocrine part. At E13.5, the epithe-
lium of the ductal system showed high sortilin IR,
primarily in the apical part and of granular appear-
ance (Fig. 5). This was also true for E15.5 and E17.5,
where the exocrine acini also showed granular sortilin
IR in the apical parts of the acinar cells, although not
as marked as the ductal cells.
In short summary, sortilin IR in the digestive system
was found at the highest levels in the epithelium of the
submandibular gland acini and ducts, and the secretory
ducts of pancreas, but was also highly expressed in the
liver in granulocytes, megakaryocytes and developing
bile ducts. Lastly sortilin IR was found in cells resem-
bling enteroendocrine cells of the gut as well as in epi-
thelia of the ventricle and large intestine.
Urinary system
Kidney
Sortilin was found expressed in the tubular system inside
the metanephros at all three age points. At E13.5 sortilin
IR was pronounced in cells expressing Calbindin-d28k, a
marker for ureteric branches [31], and developing neph-
rons (Fig. 6). Furthermore, metanephric tissue surround-
ing the ureteric buds showed expression of sortilin. At
E15.5 sortilin was differentially expressed in the epithe-
lial tubular system, with sparse reactivity in the mesen-
chyme. Most ureteric branches, now developing into
collecting ducts, showed a similar expression pattern to
that of E13.5. Some nephric tubules showed a strong
granular pattern of sortilin IR, and these had a high
cuboidal-cylindrical epithelium with sortilin predomin-
antly located in the apical part. Other tubules with a
lower, flattened cuboidal epithelium showed weaker sor-
tilin IR. In developing renal corpuscles, weak-moderate
sortilin IR was found along the parietal layer of Bow-
man’s capsule (not shown), as well as in a few cells dis-
persed in the glomerulus. At E17.5 the pattern was
similar to E15.5.
Heart and vascular system
Heart
Expression of sortilin in the heart showed a similar pat-
tern throughout E13.5, E15.5 and E17.5. Very sparse re-
activity was found in the ventricle, but contrary to this, a
Fig. 2 Sortilin (−/−) embryos might have fewer and larger lung branches. Preliminary data. Embryos were taken at E15.5 from WT and Sortilin
embryos, and cut at 10 μm thick slices on a cryotome and stained for TTF-1 (Red channel) and Hoechst (Blue channel). a shows images from WT
lung at E15.5 and b shows lung from a Sortilin(−/−) embryo. The bronchial branches appear larger and fewer in the knockout compared to the
WT, resembling a more immature lung (see pictures from E13.5 in Fig. 1 for comparison). Scale bars = 100 μm
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Fig. 3 Expression of Sortilin in the developing alimental canal and submandibular gland. Immunohistofluorescence was performed on sagittal sections (10 μm)
of embryos on embryonic day E13.5, E15.5 and E17.5. a. Sortilin is expressed in the epithelium of the midgut at E13.5 (a, a’) but is not observed in the small
intestine from E15.5 and onwards, apart from a small subset of epithelial cells (b-c’). b. Sortilin is highly expressed in the epithelium of the developing
submandibular gland and is primarily apically located (d-e’). c. Sortilin is moderately expressed in the epithelium of the developing ventricle (f, f’) and the large
intestine at E17.5 (g, g’). Green channel is sortilin, red channel is calretinin and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Ec, presumptive
enteroendocrine cell; Li, large intestine; Lu, lumen; Mg, midgut; Pc, pancreas; Si, small intestine; Su, submandibular gland branches; Ve, ventricle; Vi, intestinal villus
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moderately strong expression was apparent in the atria
(Fig. 7d, e). This spanned the wall as well as the valves.
Large blood vessels
In the vascular system, the arteries showed no expres-
sion of sortilin while the veins showed moderate to
strong expression at all three age points (Fig. 7c, f ).
Musculoskeletal system
Cartilage/Bone
Sortilin IR was generally detected at high levels in the
entire skeletal primordium as well as cartilage. In struc-
tures undergoing intramembranous ossification e.g.
skull, sortilin was expressed in the entire structure. In
structures undergoing endochondral ossification e.g. cos-
tae, sortilin expression was generally confined to cells in
the center of the structure, an area with more space be-
tween nuclei compared to the surrounding concentric
cell layers (Fig. 8a-c).
At E15.5, sortilin IR was pronounced in the cartilage
anlagen of the long bones, facial bones and vertebrae.
Furthermore sortilin was strongly expressed in costae,
cartilage of the larynx, trachea and the skull. Expression
was confined to the central cells as described for E13.5.
Furthermore, areas undergoing ossification in the spine
showed strong sortilin expression in a centered pattern
(Fig. 8d, e).
At E17.5, cartilage of the trachea and larynx as well as
costae showed similar sortilin reactivity to earlier age
points. In the ossifying spine, the pattern of expression
had changed somewhat. Sortilin IR cells were no longer
found in the center, but rather in the posterodorsal and
anteroventral parts of the vertebrae, confined to a cluster
of cells: some cells with a diameter of ~10 μm, and other
large cells at ~15–20 μm in diameter (Fig. 8f ). These
cells are possibly osteoblasts and osteoclasts, respect-
ively, where both showed a strong granular pattern of
sortilin expression dispersed throughout the cytoplasm.
Skin
The skin showed little sortilin IR at E13.5, but this in-
creased to moderate levels at E15.5 and E17.5. Expres-
sion was located in the apical part of the epidermis
(Fig. 7g-i).
Fig. 4 Sortilin expression in liver. Immunohistofluorescence was performed on sagittal sections (10 μm) of embryos on embryonic day E13.5 (a,a’),
E15.5 (b, b’) and E17.5 (c, c’). Sortilin-IR was found in megakaryocytes of all three age points, as well as in structures morphologically identified as
immature bile ducts in the vicinity of veins. Green channel is sortilin and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Bi, developing
bile duct; Mk, megakaryocyte; Ve, presumptive vein
Boggild et al. BMC Cell Biology  (2016) 17:8 Page 7 of 18
Adipose tissue
At E13.5 and E15.5, adipose tissue showed no expression
of sortilin. By E17.5, the brown (multilobular) fat deposits
in the neck and back region showed strong sortilin IR,
with a peak along the edges of deposits (Fig. 8g, h)
In summary, sortilin expression was found pronounced
in skeletal structures undergoing both endochondral and
intramembranous ossification, as well as in cartilage of e.g.
larynx. Furthermore brown fat deposits showed strong
sortilin IR by E17.5.
Endocrine system
Thyroid gland
At E13.5, the thyroid gland showed strong sortilin IR
in cells expressing TTF-1 (Fig. 9). By E15.5, folliculo-
genesis has commenced, and TTF-1 IR cells have
begun to arrange in small groups with sortilin IR in
the part of the cells facing the center. At E17.5, small
follicles are clearly visible, with strong granular sorti-
lin expression in the apical cytoplasm of TTF-1 IR
cells facing the emerging lumen.
Adrenal glands
In the developing adrenal glands, expression of sortilin
was noted at E13.5 in cells staining positive for tyrosine
hydroxylase (TH). Furthermore, cells surrounding the
TH positive cells in the adrenal glands also showed sor-
tilin IR. This expression diminished to non-detectable
levels at E15.5 and E17.5.
SorCS2
Respiratory tract
Lung SorCS2 was found expressed at high levels in the
apical parts of developing bronchi analogous to the ex-
pression of sortilin, throughout E13.5, E15.5 and E17.5,
with the exception that SorCS2 showed a less pro-
nounced granular pattern. The visceral blade of the
pleura also stained clearly for SorCS2 (Fig. 10a-c).
Digestive tract
Gut Moderate expression of SorCS2 was found in
the connective tissue of the lamina propria and
Fig. 5 Sortilin is expressed in the epithelium of the developing pancreas. Immunohistofluorescence was performed on sagittal sections (10 μm)
of embryos on embryonic day E13.5 (a, a’), E15.5 (b, b’) and E17.5 (c, c’). Sortilin is highly expressed in the ductal epithelium, and to a lesser extent
in the apical part of developing acini. Green channel is sortilin and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Ac, acini; Du,
ductal system
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submucosal layer of the developing gut at E15.5 and
E17.5 as well as the submesothelial connective tissue
(Fig. 10j-l).
Liver The liver showed strong expression of SorCS2 at
E13.5. The cells expressing SorCS2 were spherical with a
round nucleus and sparse cytoplasm around 10 μm in
diameter and SorCS2 was located perinuclear in a
granular pattern. The cells were often located together
in small groups interspersed by areas of cells without ex-
pression of SorCS2 (Fig. 10d). By E15.5 and E17.5 this
pattern of expression had diminished to very low levels.
At E15.5 and E17.5 expression of SorCS2 is noted in
vessel-like structures corresponding to central veins
(Fig. 10e, f ).
Urinary system
Kidney Throughout all three time points there was a
moderate expression of SorCS2 in the periphery of
the developing kidney, corresponding to the cap mes-
enchyme/cortical interstitium. The level of this ex-
pression remained fairly constant throughout the
three time points investigated (Fig. 10g-i).
Heart and vascular system
Heart The ventricles and atria of the developing heart
both showed weak levels of expression of SorCS2 at
E13.5. This expression was diminished at E15.5 and was
non-detectable at E17.5 (Fig. 11a, b).
Vessels Prospective small arterioles and medium-large
arteries showed prominent expression of SorCS2 in
both the systemic and pulmonic circulation. SorCS2-
IR localized to concentric cell layers in the vessel wall
disparate from the endothelium (Fig. 11c–e). Larger
veins also showed faint expression of SorCS2 in the
same pattern.
Fig. 6 Sortilin is expressed in the tubular system of the developing metanephros. Immunohistofluorescence was performed on sagittal sections (10 μm) of
embryos on embryonic day E13.5 (a, a’), E15.5 (b, b’) and E17.5 (c). Sortilin shows marked apical expression in ureteric branches and a portion of the
metanephric tubular system. This expression becomes more prominent from E13.5-E15.5 and remains stable at E17.5. Green channel is sortilin, red channel
is Calbindin-D28K and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Ki, kidney; Me, metanephric mesenchyme; Sb, S-shaped body Ub,
ureteric branch
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Musculoskeletal system
Cartilage/Bone SorCS2 was prominently expressed in
ossifying bone such as the mandible and vertebrae at
E15.5 and E17.5. The expression localized mostly to the
outer 1/3 of the ossifying area. Furthermore, SorCS2
was prominently expressed in a concentric layer of
mesenchyme surrounding the costae, sternum, clavicle
and skull (Fig. 12d, e).
Striated muscle Throughout E13.5, E15.5 and E17.5
SorCS2 was found expressed at high levels ubiquitously
in striated muscle. The expression located mainly in sat-
ellite cells closely associated with muscle cells but also
Fig. 7 Sortilin expression in mouth, heart, vascular system and skin. Immunohistofluorescence was performed on sagittal sections (10 μm)
of embryos on embryonic day E13.5, E15.5 and E17.5. Sortilin is found in the epithelium of the tongue and palate at E13.5 but is gone by
E15.5 (a,b). In the cardiovascular system, sortilin is found in the atria and large veins (d-f) but not in the arteries (c), Finally, sortilin is found
moderately expressed in the epidermal layers of the skin most prominently at E15.5 (g-i), Green channel is sortilin, and blue channel is
Hoechst nuclear stain. Scale bars = 50 μm. Ar, arteries; At, atria of heart; De, dermis; Ep, epidermis; Mo, mouth cavity; Na, nasal cavity; Pa,
epithelium of palate; To, tongue; Ve, veins, Vt, ventricle of heart
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directly to one of the repeating bands of sarcomeres in
muscle cells. The sarcomere part diminished at E17.5
(Fig. 12a-c).
Skin The connective tissue of the dermal layers of the
skin had pronounced expression of SorCS2 at E15.5 and
E17.5 (Fig. 11f, i).
Adipose tissue SorCS2 was found expressed abundantly
in the brown multilobular adipose tissue of the neck at
all three age points (Fig. 12h, i).
Endocrine system
Adrenal glands Expression of SorCS2 was prominent in
the developing adrenal gland at E13.5, confined to cells
Fig. 8 Sortilin is expressed in costae, vertebrae and brown adipose tissue. Immunohistofluorescence was performed on sagittal sections
(10 μm) of embryos on embryonic day E13.5, E15.5 and E17.5. Sortilin show marked central expression in developing costae (a-c), as well
as in the chondral primordium and later ossifying vertebrae (d-f). Sortilin expression is absent from brown adipose tissue until E17.5
where it is prominent (g,h). Green channel is sortilin and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Ba, brown adipose
tissue; Co, costae; Ve, vertebrae
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in close proximity to TH+ chromaffin progenitor cells.
This corresponds to the steroidogenic cell population.
Furthermore expression of SorCS2 was present in the
peripheral mesenchyme. By E15.5 the expression in the
steroidogenic cell population had diminished to low
levels and was undetectable at E17.5 (Fig. 11g, h).
Discussion
In the CNS, sortilin and SorCS2 show a complementary
expression with regards to cell type and subcellular dis-
tribution [2]. This disparate expression pattern might in-
dicate overlapping roles for sortilin and SorCS2 in the
CNS, in addition to their unique functions. Indeed, the
ability of both proteins to mediate apoptotic signals in
the CNS could mean that the some of the differences in
the amino-acid sequence of sortilin and SorCS2 help suit
them to mediate similar effects in dissimilar cell types.
As such it was interesting to see if these largely comple-
mentary expression patterns were also found in non-
neuronal tissues of the developing embryo. This indeed
seemed to be the case, as sortilin was mainly found in
epithelial tissues, whereas SorCS2 predominated in
mesodermally derived connective tissues.
Sortilin in the developing embryo
Sortilin has been shown to bind multiple ligands, and to
have physiological functions beyond the nervous system.
Possible roles for sortilin in the development of the em-
bryo have not been examined. We show sortilin to be
abundantly expressed in the developing embryo in a sur-
prisingly large number of organs and tissues. The most
consistent finding is that sortilin is located to the epithe-
lial tissues, and more specifically in the apical part of
these. Many of these epithelial structures undergo sig-
nificant branching in the period examined, notably lung,
kidney, pancreas and the submandibular gland. The
branching process is conceivably highly regulated and
involves a variety of intrinsic and extrinsic mechanisms
that work together to ensure the proper architecture of
the given organ [32]. Among these mechanisms are sev-
eral signaling molecules of well-known growth factor
systems including members of the fibroblast growth fac-
tor family and bone morphogenetic proteins. During
Fig. 9 Sortilin expression in the developing thyroid gland. Immunohistofluorescence was performed on sagittal sections (10 μm) of embryos on
embryonic day E13.5 (a, a’), E15.5 (b, b’) and E17.5 (c, c’). Sortilin is highly expressed in TTF-1 IR cells in the developing thyroid gland on all age
points investigated. On E17.5 the expression was localized to the apical part of TTF-1 IR cells forming follicles (c, c’). Green channel is sortilin, red
channel is TTF-1 and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Fo, emerging follicles; Tg, thyroid gland; Tr, tracheal cartilage
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Fig. 10 SorCS2 expression in embryonic internal organs. Immunohistofluorescence was performed on sagittal sections (10 μm) of embryos on
embryonic day E13.5, E15.5 and E17.5. SorCS2 is found prominently in the epithelium of the developing lung, and also the visceral pleural layer
(a-c) It is highly expressed in the liver at E13.5 (d), but diminishes at later time points and instead localizes to central veins (e,f). SorCS2 is also
expressed in the cap mesenchyme of the kidney (g-i), and in the connective tissue of the gut (j-l). Green channel is SorCS2, red channel is TTF-1
and blue channel is Hoechst nuclear stain. Scale bars = 50 μm. Br, bronchus; Cp, Cap mesenchyme; Cv, central vein; Ki, kidney; Li, liver; Lu, lumen;
Pl pleuric cavity; Si, small Intestine; SMe, submesothelial connective tissue; SMu, submucosal connective tissue
Fig. 11 SorCS2 expression in cardiovascular system, skin and adrenal gland. Immunohistofluorescence was performed on sagittal sections (10 μm) of
embryos on embryonic day E13.5, E15.5 and E17.5. SorCS2 is weakly expressed in the developing ventricle in a subset of cells (a, b). Medium-large ar-
teries show prominent SorCS2 IR while veins show weak IR (c-e). In the skin SorCS2 is found localized to the deep dermal layers (f, i). Lastly, the adrenal
gland shows pronounced expression of SorCS2 in a large portion of the cells (g) but by E17.5 this localization has changed to the periphery of the
gland, analogous to the kidney (h). Green channel is SorCS2, red channel is TH (g) or calbindin (h) and blue channel is Hoechst nuclear stain. Scale
bars = 50 μm. Ad, adrenal gland; Ar, arteries; De, dermis; Ep, epidermis; Ki, kidney; Lu, lung; Ve, vein; Vt, ventricle of heart
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epithelial differentiation, there is a substantial amount of
receptor regulation, where epithelia lose and acquire
sensitivity to different extrinsic signals as they differenti-
ate into more mature cell types. Sortilin is a multi-ligand
receptor shown to function at the level of the trans
Golgi network (TGN) in sorting a variety of molecules
between different cellular compartments [3]. Sortilin
could participate in the trafficking and regulation of
various receptors or effector molecules involved in the
branching process of these organs. The preliminary data
from the lung of a sortilin(−/−) embryo could indicate a
reduced level of branching, with fewer and larger bron-
chial branches compared to WT, however this needs to
be confirmed with a more thorough investigation. Inter-
estingly, sortilin has been shown to interact with trans-
forming growth factor beta (TGFβ) and increase its
degradation [33]. A study using a constitutively active
form of TGFβ-1 in fetal mice showed arrest of lung de-
velopment in the pseudo glandular stage, and lack of
sortilin could hypothetically result in increased TGFβ
signaling leading to delayed lung maturation [34]. The
temporal shift in sortilin expression noted in the lung is
in line with a hypothesis of sortilin playing a role in the
branching process of this organ.
The developing thyroid gland showed strong sortilin
expression through all three age points. Interestingly
sortilin has been shown to bind thyroglobulin, the pre-
cursor protein of thyroid hormones T3 and T4 [35].
Thyroglobulin is secreted from the apical side of thyroid
epithelia, the tyrosine residues are modified after which
thyroglobulin is taken up again by endocytosis and pro-
teolysed in lysosomes. Despite this, later investigations
have showed that the levels of TSH and thyroglobulin as
well as the morphology of the thyroid gland are normal
in sortilin(−/−) mice. The only difference found was re-
duced T4 levels in male sortilin(−/−) mice [36]. Whether
this is due to redundancy of sortilin in thyroid gland
function, or a question of experimental circumstances
remain to be discovered.
Another tissue with prominent sortilin IR is cartilage
and bone. Both types of tissues produce and secrete
large amounts of extracellular proteins regulated by
extracellular signals, and sortilin could be involved in
the substantial intracellular trafficking needed to effectu-
ate this [37, 38]. Furthermore, sortilin is expressed in
several other tissues ranging from blood cells to brown
adipose tissue.
Earlier studies have examined the expression of sortilin
and SorCS2. Petersen et al. investigated the expression
of sortilin in adult human tissues by northern blotting
[39]. They found expression of two different mRNA
transcripts of 8 and 3.5 kb. The 8 kb transcript was
found in high amounts in heart and skeletal muscle, thy-
roid gland, placenta and testis and in minor amounts in
kidney, colon, liver and lymphoid organs. Hermans-
Borgmeyer et al. have investigated the expression of sor-
tilin mRNA in mouse embryological development with
focus on the central nervous system. In the peripheral
organs they found the sortilin mRNA transcripts most
abundantly expressed in lung and kidney, but also in
heart and skeletal muscle [40]. Sarret et al. investigated
the distribution of Sortilin mRNA and protein in rat
central nervous system. They found that sortilin pre-
dominantly localized in cell somata as well as in the
proximal dendrites of neurons [41]. Generally, this is
well in line with our findings with the exception of
Petersen et al. who investigated adult human tissue.
While the expression of sortilin in adult human vs fetal
mouse tissue can be genuinely different there may be
other explanations as well. The localization of mRNA
transcripts and the protein sortilin are not necessarily
the same, which could also be the reason why Hermans-
Borgmeyer et al. find expression of sortilin in skeletal
muscle in contrast to us. Furthermore, Petersen et al. do
not state whether they had other human tissues available
so it is possible that they would find expression also in
lung, pancreas, salivary glands and so forth.
SorCS2
Contrary to sortilin, SorCS2 was found expressed prom-
inently in mesodermally derived structures such as
adipose tissue, striated muscle tissue and developing
bone. This could indicate a function for SorCS2 in these
tissues. A genome wide association study found that a
single nucleotide polymorphism in the locus of the
SorCS2 gene was significantly associated with circulating
levels of insulin-like growth factor binding protein 3
(IGFBP-3) in a human population [42]. IGFBP-3 binds
and regulates the bioavailability of IGF-1 in plasma, and
overexpression in a mouse model showed growth retard-
ation [43]. IGF-1 is a primary effector of growth hor-
mone, and stimulates growth of most tissues including
muscle, adipose tissue and bone [44]. Thus, it is interest-
ing to investigate whether SorCS2(−/−) show signs of
(See figure on previous page.)
Fig. 12 SorCS2 is expressed in striated muscle, costae, mandible and adipose tissue. Immunohistofluorescence was performed on sagittal sections
(10 μm) of embryos on embryonic day E13.5, E15.5 and E17.5. a-c. SorCS2 is expressed in striated muscle at all age points, localizing both in
satellite cells and in striated bands with a diminishing trend at E17.5. d-g. SorCS2 shows marked concentric expression in developing costae, as
well as in the ossifying mandible. h,i. SorCS2 is also expressed in brown adipose tissue. Green channel is SorCS2 and blue channel is Hoechst
nuclear stain. Scale bars = 50 μm. Ba, brown adipose tissue Cl, clavicle; Ma, mandible; Sm, striated muscle; St, sternum
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reduced growth. Furthermore, SorCS2 was found expressed
in several connective tissues, such as the dermis, submuco-
sal and submesothelial layers of the gut. Finally SorCS2 was
also found in the epithelium of the bronchial system, which
differs somewhat from the general localization.
Rezgaoui et al. have investigated the expression of
SorCS2 in mouse embryonic tissue by in situ hybridization
in CD-1 mice. They found SorCS2 transcripts localized to
facial mesenchyme, skeletal and smooth muscle, cartil-
aginous tissue and lung epithelial tissue. Furthermore,
they also found weak levels of expression in heart muscle
and olfactory epithelium. This corresponds well with our
findings, apart from the SorCS2 protein we see in adipose
tissue. This could be due to methodological differences as
mentioned above, or to differences in gene expression be-
tween CD-1 and C57J/bl6bom mice.
The complementary expression pattern of sortilin and
SorCS2 in some body parts raises the question whether
this also translates to complementary functions in these
tissues. This seems to be the case for dorsal root gan-
glion neurons and Schwann cells, which require sortilin
and SorCS2 respectively, for p75NTR mediated apoptosis
[2]. SorCS2 differs from sortilin in that it does not have
complete cytoplasmic tail sorting motifs needed to con-
vey transport between the TGN and lysosomes [45].
Thus it is possible that SorCS2 does not share functional
similarities in this aspect, but rather in functions on the
cell surface. It should be noted that the complementary
pattern described is not complete, as there are several
organs that contain sortilin but not SorCS2 e.g. pan-
creas, submandibular gland, and organs that contain
both proteins in the same cells (lung).
Conclusions
The developing mouse embryo shows an extensive and
distinct expression of sortilin and SorCS2 in a large variety
of tissues, with several dissimilar physiological roles pos-
sible. It is our hope that this structural characterization
will encourage new studies of the functions of sortilin and
SorCS2 in organ development.
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